CMR is the leading provider
of funding and management
support for small to
medium-sized businesses and
entrepreneurs
Established 1984 C MR
is the leading venture
capital, management
support and business
services provider for
small to medium-sized
businesses - linking
excellent management
skills with the
substantial financial
resources of a global bank
of private investors.
CMR has over 450 senior
executives, operating
in the UK, USA, Europe, Asia,
Australasia and
globally,
providing both funding and
specialist help for
entrepreneurial
businesses .
For Businesses
CMR provides excellent
resources:
CMR FundEX Business Exchange - gives all companies & entrepreneurs direct access to CMR's global investor base.
CMR Catalyst Group
Programme -
transform
profitability through
merging.
CMR Company Sales Division helps owners to exit
at the best price.
CMR Corporate Recovery
Division -
experts in rescue and
turnaround.
CMR Technology Licensing
Division -
commercialising
innovation.
CMR Executive
Professionals - management support
and consultancy.
CMR Executives-on-Demandâ„¢ Fully experienced
senior executives
available quickly and
cost effectively.
We always welcome
contact with new
business clients- please get in touch
- we will do our
best to match
your needs and exceed
your expectations.
For Investors
Preferential access to new opportunities for investment and/or acquisition
P re-vets
propositions and
provides a
personalised service
to our investors
Syndication service
enabling investors to
link together as desired
Executive and
management support for
investments as needed
CMR's services to
our investors are not
only fast & efficient
but also free
W e
always appreciate new
members- you are welcome
to join as an investor
or as a CMR Executive.
When you
join us as a Senior
Executive:
CMR's strength is in the
skills and experience of
our executive members -
all senior, director level
people with years of
successfully running and
managing companies.
Because the demand for
CMR's support and services
is ever-increasing,
especially as we enter
recessionary times, we
have a growing need for
more high calibre
executives to join us from
every industry and
discipline.
You will be using your
considerable experience to
help smaller businesses
and entrepreneurs to grow
profitably.
We offer full training
and mentoring support to
help maximise potential.
We are
always keen to find more
high calibre senior
executives in all areas-
skills and location.
Make contact with us today
and maximise your
opportunities.
HEAD
OFFICE
124 City Road
London EC1 2NX
Tel: +44 (0)207-636-1744
Fax:+44 (0)207-636-5639
Email: cmr@cmruk.com
Registered Office:
124 City Road ,
London EC1 2NX
Also Glasgow,
Dublin, Switzerland, Europe, USA/Canada
Privacy Statement: CMR only
retains personal details
supplied directly by executives
joining CMR themselves either as
Full Executive Members or
Interim Management Members or
Investors. Those details are
only used within CMR and not
disclosed to any third parties
without that person’s
agreement. We will keep that
data until requested by the
person to be removed – at that
point it will be deleted.
Personal data is never sold or
used for purposes outside of
CMR’s normal operations. Any
correspondence should be
directed to the Managing
Director, CMR,
Kemp House,
152-160 City Road, London EC1V
2N
Senior Executives
CMR is a worldwide network of senior executives. Join us to expand your career and business horizons.
Business Entrepreneurs
CMR has a complete range of resources & services provided by experts to help all businesses to grow and prosper.
Investors & Venturers
CMR has a continuous stream of business and funding propositions, which are matched to investor preferences. Join us - it's FREE!
FundEX
FundEX is CMR's worldwide stock market for small to medium sized companies and entrepreneurs to raise new capital.
Interim & Permanent Management
Many of CMR's executives can be recruited on an interim, permanent or NED basis.
Login
Main CMR Intranet members only
Regional Intranets
Thu, 19 Nov 2026 02:20:00 +0000 Harvard Study Reveals What Happens When Schools Lock Up Kids' Phones
Harvard Study Reveals What Happens When Schools Lock Up Kids' Phones
Shocker... Schools that locked students' phones away for the whole school day saw math and reading scores grow faster , by about one to two
Read more.....
Harvard Study Reveals What Happens When Schools Lock Up Kids' Phones
Shocker... Schools that locked students' phones away for the whole school day saw math and reading scores grow faster , by about one to two extra weeks of learning a year, according to a Harvard study of 3.3 million students released Tuesday.
The study , from Harvard's Center for Education Policy Research, followed students at 4,600 schools from the 2021-22 through the 2025-26 school years. Strict bans - lockable Yondr-style pouches, phones stored centrally, or phones kept off campus altogether - raised annual achievement growth by about 0.01 standard deviations , roughly half of what students have been losing each year since smartphones went mainstream.
"Student achievement has been declining since about 2013 in the U.S., in what we call a 'slow leak' in the paper," Thomas Kane, the center's faculty director and a co-author, told the Harvard Gazette . He wrote the paper with Dartmouth's Douglas Staiger and the testing group NWEA, and it has not been peer-reviewed, NPR reported.
Kane gave the AP the bottom line: "Our answer is yes, phone bans do have a positive effect on growth. But it's not a panacea."
Bans that left it to teachers to police phones in their own classrooms did less, he said. "The key idea is that you're not relying on teachers to enforce it, with inevitably some teachers more lax than others."
The bans also appear to protect the students who were sliding fastest. "Among all students, regardless of their baseline achievement, there's a subset who were seeing big losses in reading over the course of the year, and bans seem to stop that loss," Kane said.
At about $25 a student, or roughly $425 a classroom, the pouches are cheap next to the cost of buying the same gains with extra instruction time , Kane says. The study's pouch estimates rest on student-level scores at 844 schools that used both Yondr's pouches and NWEA's tests, according to NPR, out of more than 3,300 schools nationwide that adopted the pouches between 2019-20 and 2025-26.
Another national study, released this spring, found the same pouches had "close to zero" effect on test scores. That team, led by Stanford's Thomas Dee with researchers from Duke, the University of Michigan and the University of Pennsylvania, tracked more than 43,000 middle and high schools over three years. It found a slight bump in high school math and a slight drop in middle school scores; disciplinary incidents rose in the first year before returning to earlier levels by the third, when student well-being was higher than before the bans.
"The early results from school phone bans are largely disappointing and raise unresolved questions," Dee told the AP. Michigan's Brian Jacob, one of his co-authors, called the Harvard results "encouraging" but told NPR we'll have to "wait and see" whether the benefit lasts.
As of November, 41 states and Washington, DC, have statewide school phone policies, according to the Harvard report, which found suggestive evidence that state-mandated bell-to-bell and instructional-time bans lifted achievement last year , while cautioning that those results could be confounded by trends already underway in the states that passed them.
San Diego State University psychologist Jean Twenge told the AP that enforcement is often spotty: students find workarounds, and some schools with bans on the books still have phones everywhere.
Kane calls students' phone and social media use outside school "the big question." He wants states to demand usage data from the social media companies , and points to the roughly $17 billion Meta agreed to pay states this year, rather than fight their lawsuit over data collection and addictive app design, as a way to pay for the research.
Tyler Durden
Wed, 11/18/2026 - 21:20
Close
Thu, 19 Nov 2026 02:00:00 +0000 NIH Targets Fauci's Secret Role In Lab Leak Cover-Up Paper
NIH Targets Fauci's Secret Role In Lab Leak Cover-Up Paper
NIH Targets Fauci's Secret Role In Lab Leak Cover-Up Paper
Authored by Steve Watson via Modernity ,
The Trump administration has formally demanded that Nature Medicine investigate whether Anthony Fauci, Francis Collins and Sir Jeremy Farrar secretly shaped the 2020 paper that became the decisive weapon against the COVID lab-leak theory.
In a letter from NIH Director Jay Bhattacharya, the agency called for a "formal, independent investigation" into allegations of ghostwriting and undisclosed contributions, and told the journal to consider correction or retraction .
The paper, "The Proximal Origin of SARS-CoV-2," appeared in March 2020 under the names of Kristian Andersen, Andrew Rambaut, Ian Lipkin, Edward Holmes and Robert Garry. It concluded that "we do not believe that any type of laboratory-based scenario is plausible."
The paper was cited millions of times, amplified by media and public-health officials, and used by Fauci himself from the White House podium in April 2020 to shut down questions about the Wuhan Institute of Virology.
Congressional records and later-released emails show the three senior figures participated in the February 1, 2020 teleconference that launched the effort, received drafts, and were thanked in a March 6 email for their "advice and leadership."
Farrar convened the call, circulated drafts and made at least one direct edit. None of the three was named as an author or acknowledged contributor.
The NIH letter states: "Although its acknowledgements identify support from the NIH and Wellcome Trust, they do not name Anthony Fauci, Francis Collins or Jeremy Farrar as authors or contributors."
Private communications reveal a stark contrast with the public certainty. Farrar estimated a 50:50 chance of a lab accident and described Wuhan research as "like the Wild West." Collins warned that further discussion could damage "international harmony" and called for a "confidence-inspiring framework" to silence the "voices of conspiracy."
Co-author Andrew Rambaut wrote: "My feeling is we should say there is no evidence of a specifically engineered virus, we cannot possibly distinguish between natural evolution and escape, so we are content with ascribing it to a natural process." Months after publication, Andersen still privately said "we can't rule it out."
Bhattacharya has emphasized that "Intellectual contributions play a central role in shaping the scientific story. Authorship and acknowledgement in scientific publications must accurately and ethically reflect all substantive input."
The demand follows an HHS advisory opinion examining disclosure of contributions, which specifically referenced the Nature Medicine paper and the involvement of Fauci, Collins and Farrar.
This latest step sits within a longer record of efforts to manage the origins narrative. Fauci's own diary entries from 2021-2022 show him attributing the rise of the lab-leak theory to Trump's decision to cancel an NIH grant to EcoHealth Alliance for work at the Wuhan lab.
He wrote that "the entire controversy with China as the source of the outbreak and the lab leak theory stems from the tension between Trump and China" and claimed the cancellation occurred "with no evidence to support any suspicion."
Court documents later showed Peter Daszak of EcoHealth sending wine to Fauci's senior adviser David Morens and thanking him for "behind the scenes shenanigans in my battle against your bosses boss, his boss and the ultimate boss on the hill."
Morens used private email to evade FOIA requests while working to restore EcoHealth funding and counter the lab-leak narrative. Daszak also organized the Lancet letter that branded lab-leak discussion a conspiracy theory.
CIA operations officer James Erdman III testified in May 2026 that Fauci intentionally influenced the intelligence community's assessment. "Dr. Fauci's role in the cover-up was intentional," Erdman said.
He added, "Dr. Fauci influenced the analytical process and findings by leveraging his position to ensure the IC consulted with a conflicted list of curated subject matter experts, public health officials, and scientists."
Analysts had repeatedly concluded a lab origin was most likely; those findings were softened or set aside.
In April 2025 the White House released a detailed assessment concluding that a lab-related incident involving gain-of-function research was the most likely origin .
It noted that the Proximal Origin paper was prompted by Fauci to advance the natural-origin narrative and was then used to discredit the lab-leak hypothesis.
The report cited the absence of any identified intermediate host, the virus's features, the location of the outbreak, and the research conducted at the Wuhan Institute of Virology under inadequate biosafety conditions.
The authors of Proximal Origin have maintained that their conclusions reflected the scientific process and that Fauci and Collins did not direct the outcome. A Democratic staff review found no evidence of direction.
Critics, including scientists who have examined the private messages and the paper's claims, argue the public presentation systematically understated laboratory risk while private assessments continued to treat a lab origin as plausible.
The NIH letter does not itself declare the paper fraudulent. It asks Nature Medicine to determine whether the published byline and acknowledgments accurately reflect who contributed , and to act if they do not.
That is a narrower question than the broader debate over the virus's origin. It is also the first formal institutional demand under the current administration for the journal that published the single most influential early document used to close that debate.
Tyler Durden
Wed, 11/18/2026 - 21:00
Close
Thu, 19 Nov 2026 01:40:00 +0000 Wall Street's Climate Cartel Faces New Scrutiny Over "Blatant Weaponization"
Wall Street's Climate Cartel Faces New Scrutiny Over "Blatant Weaponization"
Wall Street's biggest banks may have walked away from their virtual-signaling climate pledges, but a conservative consumer watchdog alleges that th
Read more.....
Wall Street's Climate Cartel Faces New Scrutiny Over "Blatant Weaponization"
Wall Street's biggest banks may have walked away from their virtual-signaling climate pledges, but a conservative consumer watchdog alleges that the policies behind them could still be freezing lawful businesses out of the financial system .
JPMorganChase global headquarters, 270 Park Avenue NYC
In a leter to the Comptroller of the Currency (OCC), Consumers' Research urged federal regulators to investigate JPMorgan Chase, Citigroup, Bank of America and Morgan Stanley over concerns that environmental policies are dictating which businesses get access to financial services . The letter was firsted reported by Daily Caller .
Consumers' Research executive director Will Hild tore into the banks, accusing them of "blatant weaponization" of the financial system.
"For years, banks have been using their outsized influence to punish their political enemies through debanking for political and religious reasons," Hild told Daily Caller . "This practice of cutting off access to bank accounts, lines of credit, and essential financial services has been a blatant weaponization by the banking industry. We hope this information allows the OCC to continue its tireless work ensuring the finance industry stops this woke debanking practice."
The push to investgation the banks comes amid the Trump's administration crackdown on politically motivated debanking.
Although JPMorgan Chase, Citigroup, Bank of America and Morgan Stanley all withdrew from a major United Nations-backed climate alliance by early 2025, some maintained their environmental commitments, raising questions about how much their underlying banking policies have actually changed.
Such concerns intensified after a recent OCC investigation found nine major banks maintained policies that potentially encouraged discrimination against customers based on their political beliefs, religious affiliations or business activities. The probe identified restrictions targeting oil and gas producers, coal companies and firearms manufacturers.
"Notwithstanding certain efforts by the largest banks to rein in these practices, I am not confident that they will be enough," OCC Comptroller Gould said in a statement at the time. "Accordingly, the OCC will be assessing further changes to the regulatory and supervisory framework applicable to the largest banks to reduce the likelihood of these harmful practices recurring in the future."
Tyler Durden
Wed, 11/18/2026 - 20:40
Close
Thu, 19 Nov 2026 01:20:00 +0000 Houthis Are 'Occupying' Part Of Saudi Arabia, Tucker Carlson Claims
Houthis Are 'Occupying' Part Of Saudi Arabia, Tucker Carlson Claims
Houthis Are 'Occupying' Part Of Saudi Arabia, Tucker Carlson Claims
Via Middle East Eye
Conservative US podcaster Tucker Carlson said that Yemen’s Houthis are “occupying” parts of Saudi Arabia, and that the American media is not covering the wartime development.
“The Houthis are legitimately threatening the Saudi kingdom right now,” Carlson said in a podcast, released on Monday, where he interviewed American geopolitical analyst Brandon J Weichert. “They are occupying part of Saudi right now … I don’t know if this is even covered in the American media, but it’s a fact. It’s a really big thing,” he said.
“Are there Houthi forces on Saudi soil right now? There are ,” he added.
via Associated Press
Carlson did not say where he obtained the information about a Houthi “occupation” of Saudi territory, but the media personality often speaks with senior Arabian Gulf leaders .
The Financial Times reported in October that Carlson visited “certain Arab Gulf royals on their Mediterranean yachts” . Carlson claimed in his interview that he spoke to leaders in the Gulf “this week”.
Carlson has criticized the US defence and intelligence establishment, but he counts Vice President JD Vance as a friend. Although he has blasted President Donald Trump over the war on Iran and Israel, he told Weichert that he recently had a long conversation with the US president.
'Houthi incursion' Carlson’s claim follows an exclusive report from Middle East Eye on November 2, citing western and Arab officials, that the Houthis were launching raids into Saudi Arabia. The sources said that the raids took place in October, but did not confirm that the Houthis were still holding Saudi territory.
Saudi Arabia’s rugged border with Yemen is effectively off limits to journalists. The terrain is a mix of mountains and vast desert . Whole villages there were uprooted after the last round of fighting in Yemen, which saw the Houthis launch cross-border incursions into Saudi Arabia.
Fighting between the Houthis and the Saudi-backed, internationally recognised government is focused inside Yemen’s borders. The Houthis are moving towards the port city of Aden, the government’s provisional capital.
But the Houthis have openly spoken about their territorial ambitions in Saudi Arabia. The Houthis lay claim to the kingdom’s three southern provinces of Asir, Jazan and Najran, which Yemen ceded to Saudi Arabia in the 1934 Treaty of Taif .
The Houthis originated in Yemen’s Saada governorate, the mountainous region south of the border with Saudi Arabia.
The movement takes its name from its founder, Hussein Badreddin al-Houthi and follows the Zaydi sect of Shia Islam. The Houthis recruit across Yemeni society, but their senior leadership claims Hashemite descent, which would link them to the Prophet Muhammad.
Carlson also said that he believes the Houthis are being aided in their war effort by backers other than Iran, who hope to see the kingdom of Saudi Arabia weakened.
“You do wonder who is controlling the Houthis ,” he said. “I think Iran has had a huge effect on the Houthis, but is that the only power that is behind this?” he said.
Carlson did not say who he believes is supporting the Houthis, but Dropsite News reported in October that Yemeni factions backed by the UAE were quietly assisting the Houthis in targeting advice.
Tyler Durden
Wed, 11/18/2026 - 20:20
Close
Thu, 19 Nov 2026 00:45:00 +0000 Watch: Musk Shreds 'Russian Apologist' Smears, Exposes Zelensky's Starlink Lies At NYT DealBook Summit
Watch: Musk Shreds 'Russian Apologist' Smears, Exposes Zelensky's Starlink Lies At NYT DealBook Summit
Update(1925ET) : Among the more interesting and explosive stand-out parts of the NY Times' DealBook
Read more.....
Watch: Musk Shreds 'Russian Apologist' Smears, Exposes Zelensky's Starlink Lies At NYT DealBook Summit
Update(1925ET) : Among the more interesting and explosive stand-out parts of the NY Times' DealBook Summit interview with Elon Musk (Musk joined remotely from China), Andrew Ross Sorkin pressed him on accusations that he's a Russian apologist or else Kremlin-sympathetic. Related to this were also segments on President Zelensky's claim of using Starlink, not Starshield (which is controlled by the US government), for offensive strikes against Russia - something which Musk responded by pointing out: "That's false... I don't want to blow your mind, but Zelensky is not always truthful ."
Another bombshell line (though which not exactly a revelation for longtime ZH readers), came when Musk said in front of the audience something a NY Times audience is not used to hearing: "It is also true that we staged a coup to overthrow the democratically elected" government of Ukraine - speaking of US government covert and political intervention in the 2014 Maidan events. According to Musk...
"Let me anticipate your questions: 'Is Russia the aggressor?' Russia is the aggressor, but it's also true that we as America staged a coup to overthrow the democratically-elected pro-Russian President of Ukraine." He pointed out that this constitutes an "offensive action" in and of itself , and that "without State Department and other agency help, this would not have happened." Watch:
He also sought to set the record straight on SpaceX's role related to Ukraine - and also what it is not responsible for, explaining Starlink fundamentally saved Ukraine from collapse, but also rejected the idea that he throttled it: "There is no private individual who has helped Ukraine more than I have. I made sure that Starlink was in Ukraine, prepositioned ahead of the Russian invasion," he said.
He continued to put this in context of the absurd charge that he's 'pro-Russian': "When Russia invaded, they disabled all communications, all cell towers, all fiber cables, and every satellite communication system. There was one system they could not disable, and that was Starlink ," he explained.
"If they had not had Starlink, their entire line would have collapsed because they had no communication system, and Russia would have won. Now, does that sound like a pro-Russian action to you?”
Elsewhere, he asserted: "I don’t want Starlink commercial to become party to a war , which we would be if we allow Starlink to be used for offensive military operations...And we’ve not turned off Starlink. This is false." Also this:
"SpaceX has resulted in 2/3rds reduction of Russian space activity...I'm not exactly someone who has aided Russia . We have no business in Russia. We have nothing in Russia."
And he further delineated: "From the beginning, I said that Starlink is a civilian system. It is not meant to be used for offensive drone strikes that kill people. If you want to do that, you need to do Starshield, which is a separate system that is controlled by the US governmen t."
"In the Starlink system, there is a speed limit. That speed limit is the speed of the fastest road speed limit in Ukraine, which I think is about 80 miles an hour."
More from the transcript: "Do not ask me as a private individual to make kill decisions that sometimes result in the loss of innocent lives, not just soldiers. That is not my position to do. And yet we’ve been pressed relentlessly to do that, which I think is outrageous .”
He further pointed out: "Those are the rules that have been in place since the beginning, for years . Now people pressure me to change it, but I’m not changing it."
* * *
We detailed of this dangerous and highly significant escalation earlier in the day...
The early Tuesday major Ukrainian attack on Crimea's Kerch Strait Bridge was one of the most significant strikes on Russian territory and assets of the recent war, and could prove as a turning point leading to further serious escalation - given Moscow is not going to sit idly by.
As a reminder, President Zelensky was quick to boast about the destruction of the main span of the bridge, which lies in a mangled concrete and steel mess in the Kerch Strait, blocking the ship lane. What's more is that Zelensky in a rarity named the specific weapons systems used - among them a key foreign-made weapon.
source: Destinus
"Today, at the key stage, the 'Palianytsia' drones performed exceptionally well, striking the road section of the bridge, while 'Neptune' missiles, 'Ruta’ drones , and FP-5 drones struck the railway section. Using 'Flamingo,' our warriors carried out a precision-guided strike, and the communications uplink worked flawlessly until the very last seconds," Zelensky wrote on X.
Soon after, Dutch arms manufacturer Destinus stepped out of the shadows and openly proclaimed its role, stating that seven of its RUTA missiles destroyed part of the crossing .
"We are proud to support the Ukrainian defence forces in their fight to defend Ukraine and Europe," the Hengelo and Valkenburg-based company announced in a LinkedIn post . It marks the first time that Destinus has ever publicly claimed that its weapons were behind attack operations by Ukraine .
"Last night’s strikes damaged the bridge's upper load-bearing structure. Today, seven RUTA missiles hit the bridge, causing one span to collapse ," Destinus wrote in the Tuesday post.
The European start-up further revealed that its LORD and Da Vinci unmanned systems "were also deployed to suppress Russian air defences" amid the riskey operation. A spokesperson for the company has also told European outlets , "we felt it was important to show that technology developed in Europe, together with Ukrainian weapons, can make a concrete contribution to the defense of Europe."
Did this effectively just make The Netherlands a target for Russian retaliation or potential sabotage attacks?
Image: Supernova+
The Russian Embassy in the Netherlands on Wednesday is demanding answers. Destinus could now be in the crosshairs :
According to missile expert Fabian Hoffman, the current announcement just puts Destinus on the map — and not in a good way.
While the publicity from a successful attack can bring new customers, “we know that Russia has gone after these types of companies in Europe,” he tells NOS.
And, arguably, Destinus is on Russia’s radar already. Earlier this year, Russia’s Ministry of Defence named the company on a list of European weapons producers. Dmitry Medvedev, deputy chairman of Russia’s Security Council, stated that the sites on that list should be seen as legitimate targets .
The Russian Embassy said in a statement on X, "Moscow has been duly informed of the NL (Netherlands) involvement ."
"The confession has been well noted. Is The Hague openly joining the conflict?" it questioned.
This episode may go down in history as the first time LinkedIn has played a role in a start-up confessing its involvement in stoking a major regional war, and which portends significant escalation. Most defense firms have been content to provide their weapons covertly and in silence while not poking the Russian bear too loudly, but apparently Destinus - despite it being a young and small company - has come out of the gate swinging. Helping launch WW3 just for some clout?
Tyler Durden
Wed, 11/18/2026 - 19:45
Close
Thu, 19 Nov 2026 00:40:00 +0000 The Fake 96,000-Patient Database That Sank Hydroxychloroquine... And Medicine's Growing Black-Box
The Fake 96,000-Patient Database That Sank Hydroxychloroquine... And Medicine's Growing Black-Box
The Fake 96,000-Patient Database That Sank Hydroxychloroquine... And Medicine's Growing Black-Box
Authored by Maryanne Demasi via Brownstone Institute ,
On May 22, 2020, the Lancet published a study that changed the course of the Covid-19 pandemic.
It purported to analyze the medical records of 96,032 patients hospitalized with Covid-19 across 671 hospitals and six continents , delivering a damning conclusion about an old antimalarial drug - hydroxychloroquine .
Patients treated with hydroxychloroquine alone or with a macrolide antibiotic appeared more likely to develop dangerous heart rhythm disturbances and more likely to die.
The study's findings dealt a major blow to hydroxychloroquine - a cheap, off-patent drug that was already at the center of a fierce political battle.
President Donald Trump had publicly championed hydroxychloroquine as a potential Covid treatment and called for research to be accelerated - even revealing that he was taking the drug himself.
Within days of the study appearing in the Lancet , the World Health Organization suspended the hydroxychloroquine arm of its multinational Solidarity trial. Other trials were interrupted, and treatment policies changed around the world.
The study carried enormous authority because of its size. Nearly 100,000 patient records appeared to provide the kind of real-world evidence clinicians desperately wanted while conventional randomized trials were still underway.
But there was a problem - investigators quickly concluded the database was fake .
The company behind it was Surgisphere , an obscure Chicago operation. What followed was one of the most extraordinary scientific collapses in modern history, exposing how easily global health policy could be swayed by unverified data.
Six years later, Surgisphere is worth revisiting - not as a one-off pandemic anomaly, but because the weakness it revealed in modern healthcare data has only become more consequential .
The Sleuths Among those scrutinizing the Lancet paper was physician James Todaro, who had been closely following the emerging hydroxychloroquine literature.
Todaro wasn't surprised that hydroxychloroquine showed little benefit in severely ill patients. What caught his attention was the substantially higher mortality - an extraordinary safety signal for a cheap, decades-old drug with a well-established safety profile.
Clinicians, statisticians, epidemiologists, and independent researchers began pulling apart the paper.
One of the first major discrepancies came from Australia. The study claimed to include 600 Australian patients from five hospitals, with 73 deaths recorded by April 21, 2020. But only 67 Covid deaths had been recorded in the entire country by that date.
Something wasn't adding up. The data contained more Australian deaths than Australia itself had recorded.
The Guardian contacted hospitals in Melbourne and Sydney whose participation would have been necessary to reach the numbers reported in the paper. All denied contributing to the database and said they had never heard of Surgisphere.
The company said one Asian hospital had accidentally been assigned to Australia. The figures were corrected, and the authors maintained that the mistake did not alter the conclusions.
But researchers kept looking.
The study also claimed to contain detailed clinical data from hospitals across Africa , including information derived from continuous cardiac monitoring.
Collecting and transmitting that level of granular, near-real-time information requires expensive and sophisticated electronic hospital infrastructure - technology that many African hospitals simply did not have.
Researchers questioned how Surgisphere could possibly have obtained such comprehensive electronic records from facilities where the systems needed to generate them were unlikely to exist.
Then there was North America. The study claimed to have records for approximately 63,000 hospitalized Covid patients from the region - roughly equivalent to the total number of Covid hospitalizations reported across the entire United States at the time.
If the numbers were genuine, Surgisphere had somehow captured detailed clinical records for virtually every hospitalized Covid patient in America, across hundreds of independent hospitals using different electronic medical-record systems.
It was an extraordinary claim. If true, Surgisphere had accomplished something that major health systems and technology companies had struggled to achieve for years: connecting hundreds of hospitals using different electronic medical-record systems and extracting detailed, standardized clinical information on tens of thousands of patients across multiple countries, almost in real time.
Todaro later described a database with that capability as the "holy grail" of medical research. The idea that an obscure company had quietly built it without anyone in the field knowing about it was increasingly difficult to believe.
The Company Behind the Data A global healthcare database spanning hundreds of hospitals would require substantial technical infrastructure - software engineers, database architects, statisticians, data-security specialists, and clinical informatics teams.
But investigators found nothing resembling such an operation.
Surgisphere's website was heavy with references to artificial intelligence, machine learning, and advanced analytics, but provided little evidence of how its vast international data network actually operated.
Its public footprint showed only a handful of employees and no visible army of data engineers capable of building and maintaining the system described in the papers.
The company's founder and lead author, Sapan Desai, was a vascular surgeon who had also written science-fiction novels.
Media investigations uncovered even stranger details about the small group of people associated with the company. The Guardian revealed that one employee, listed as a marketing executive, was an adult model and events hostess .
As researchers and journalists dug deeper, pages disappeared from Surgisphere's website, and claims about academic relationships were altered or removed.
The company had supposedly built a research asset of extraordinary value - a database spanning hundreds of hospitals and tens of thousands of patients that would ordinarily generate years of publications across numerous diseases.
If only it were true.
Who Had Actually Checked the Data? The Lancet paper contained an important declaration: all four authors stated that they had full access to the data and accepted responsibility for its integrity.
But that assurance soon unraveled.
On June 2, 2020, more than 200 scientists, clinicians, and statisticians signed an open letter detailing serious concerns about the study's methods and data, and demanding independent validation.
An audit could have resolved the dispute.
But when asked to provide the data, the study's lead author, Harvard cardiologist Professor Mandeep Mehra, reportedly replied: " Our data sharing agreements with the various governments, countries and hospitals do not allow us to share data unfortunately ."
Three of the four authors then said they could no longer vouch for the primary data because they had been unable to complete an independent review.
By June 4, 2020, it was all over. The authors abandoned the study, and the Lancet retracted it . On the same day, the New England Journal of Medicine retracted another Covid study built on the same database.
A Failure Beyond Surgisphere The scandal was widely treated as an extraordinary case of scientific fraud during a chaotic time, but its true significance lies in what it exposed.
Neither the peer-reviewers nor the journal editors had verified the underlying data, and outside researchers were barred from inspecting it. None of that stopped the study from rewriting global health policy overnight.
Recognizing the failure, the Lancet published a statement in September 2020 titled "Learning from a retraction ," introducing new safeguards for research reliant on large datasets.
The journal mandated that multiple authors directly access and verify raw data, required data-sharing statements, and introduced specialized data-science peer review.
These reforms were a clear admission of systemic failure, but they left a critical flaw unresolved .
Requiring authors to verify the dataset delivered to them is not the same as requiring them - or independent researchers - to verify those data against the original source medical records.
Six years later, that distinction has become critical. Modern medicine is embracing real-world evidence at an unprecedented scale , relying on massive aggregations of electronic health records, insurance claims, and disease registries to evaluate major drugs and vaccines.
Massive datasets containing the health records of millions of patients now underpin thousands of studies on drug safety, vaccines, and treatment effectiveness.
Regulators are increasingly relying on them too.
Last December, then-FDA Commissioner Marty Makary announced plans to expand the agency's use of "real-world evidence" in regulatory decisions.
"We're removing unnecessary barriers that have prevented us from using powerful real-world evidence to get life-changing treatments to patients faster," Makary said.
There are valid reasons for the shift. Electronic health records covering millions of patients can reveal rare side effects and long-term outcomes that clinical trials may be too small or too short to detect.
But there is a problem. Much of this research relies on enormous, heavily processed datasets that researchers and independent reviewers cannot readily check against the original hospital records.
The danger became clear during the Surgisphere scandal in 2020, when the database underpinning a major Covid-19 study that influenced health policy turned out to be fake.
Six years later, the same fundamental problem remains.
If neither researchers nor independent reviewers can trace the data back to the original medical records, how do we know they are reliable?
Who Controls the Data? Patient records are scattered across thousands of hospitals, stored in different computer systems, and protected by strict privacy laws.
Before researchers can analyze them, those records must be extracted, stripped of identifying information, converted into standardized codes, and assembled into research-ready databases.
The use of these datasets has exploded. A PubMed search for "real world evidence" or "real world data" shows how rapidly the field has grown over the past two decades (see graph).
Between the original medical record and the scientist who eventually analyzes it sits something of a black box.
This has created a powerful role for middlemen - companies and research networks that extract, process, and package medical records into datasets for researchers to analyze.
Commercial data companies, such as IQVIA , TriNetX and Merative , along with research networks such as OHDSI and PEDSnet , now occupy this space.
They largely draw on real patient data from electronic health records, Medicare, insurance claims, and other healthcare databases.
But some, such as OHDSI, can also work with synthetic data - artificially generated patient records that mimic the characteristics of real healthcare data but do not represent actual patients.
By the time researchers receive the data, the records may already have passed through multiple stages of extraction, coding, filtering and software transformation.
Several organizations involved in this process also have financial ties to the pharmaceutical industry.
TriNetX, for example, received venture backing from Merck's Global Health Innovation Fund. OHDSI was launched by Janssen, and receives financial support from pharmaceutical companies including Takeda, Janssen, AstraZeneca, Merck and Pfizer.
Those relationships do not mean the databases are inherently corrupted or biased, but when organizations involved in processing the data also have commercial interests, independent scrutiny of how the data are handled becomes even more important.
The Secrecy of PEDSnet PEDSnet provides a window into how this data pipeline works.
This large US research network turns electronic health records from major children's hospitals into datasets for medical research. During the pandemic, it was used for influential studies examining the safety and effectiveness of Covid-19 vaccines in children.
In 2024, researchers published a study using PEDSnet data to evaluate Pfizer's Covid vaccine in adolescents. The result was striking.
The authors reported 98.4% effectiveness against documented infection in adolescents during the Delta wave, with no statistically significant waning after the first dose - effectively claiming near-perfect protection.
Another high-profile PEDSnet study later reported that Pfizer's vaccine was 95.4% effective against long Covid in adolescents during the Delta period, based on records from 20 US health systems.
To some researchers, those extraordinary figures seemed "highly implausible," prompting them to look more closely at the underlying data. But when they tried to re-examine them, they hit a wall.
The paper stated that the data were "not publicly available due to privacy concerns," adding that they "may be available through submitting PEDSnet Study Approval applications."
In a public exchange on X, one of the study's senior authors, biostatistician Professor Jeffrey Morris, stated, "I don't know and don't have access to those data."
Morris later explained that access was governed by strict consortium protocols.
"The PEDSNet data is a consortium repository of complete medical records for millions of children so...they are not 'public' by law," he said, adding that his colleagues "are not at liberty to share the data."
One of the papers, however, stated that eight authors had "accessed and verified the data." Corresponding author Christopher Forrest was among them.
MD Reports contacted the authors, including Forrest, asking about data access, but there was no response. PEDSnet also did not respond.
It therefore remains unclear what was actually verified - and whether anyone checked the research dataset against the original hospital records.
So when scientists say they have "verified" a dataset, what exactly have they verified?
Who Gets to See the Underlying Data? A 2021 report prepared for the US Department of Health and Human Services provides a rare look inside these research networks.
It examined 15 major networks, including PEDSnet , PCORnet , FDA Sentinel , and OHDSI .
Access to patient-level information is tightly controlled. The report noted that "only authorized individuals at each data provider organization have access to patient-level information ."
Outside researchers can submit instructions specifying what they want analyzed. Depending on the network and project, they may receive deidentified or aggregated results - sometimes only summaries - rather than the underlying medical records.
These restrictions are intended to protect patient privacy. But deidentifying, summarizing, enhancing, and imputing data requires additional processing, and each step creates another opportunity for errors or distortions to creep in.
The HHS report itself warned that automated quality checks cannot catch every error. Data that pass validation can later be "found erroneous in unexpected ways, even in environments with long-established data workflows ."
That goes to the heart of the problem.
Researchers are often unable to check whether the data they receive faithfully reflect what was originally recorded at the hospital. If an error was introduced before the dataset reached them, it may simply pass through unnoticed.
That is precisely what Surgisphere exposed - researchers analyzed a database they believed contained genuine hospital records, without being able to verify those records at their source.
Compounding the problem, independent researchers trying to scrutinize or replicate published findings often struggle to obtain the dataset at all.
The result is a black box at both ends - researchers cannot verify the data against the original medical records, and outsiders cannot independently check the data after publication .
When Researchers Get to Check A recent dispute over HPV vaccination in Scotland shows what can happen when researchers are given access to the underlying data.
The original Scottish study used national health registry records and made international headlines after reporting "zero cases" of invasive cervical cancer among women vaccinated against HPV at ages 12 or 13.
Two Australian researchers, Associate Professors Samir Saidi and Mark Jones, requested the underlying dataset from the Scottish researchers.
They received it in full, deidentified and without financial cost or legal restrictions.
When Saidi and Jones reanalyzed the anonymized data, the picture changed dramatically.
They found key differences between the vaccinated and unvaccinated groups, questioned the population figures used in the analysis, and argued that the celebrated "zero cancer" finding was largely explained by the women's young age and short follow-up .
The merits of the statistical debate aside, the important point is that the data could be checked. There was no black box, and without access, the problems Saidi and Jones identified would probably never have surfaced.
The Reproducibility Problem That kind of scrutiny is fundamental to science. Important findings should be open to independent checking and replication.
NIH Director Jay Bhattacharya has made replication and reproducibility a major agency-wide priority.
The NIH describes replication and reproducibility as "foundational to the conduct of gold standard science," with its new initiative focused on data sharing, standardization, and independent replication.
That push now extends to the provenance of real-world data. The NIH's new Data COUNTS initiative aims to preserve the "full data provenance and lineage" of electronic health records - allowing researchers to trace where the data came from and what happened to them along the way.
Longstanding NIH publishing principles state that, where ethically appropriate, "all datasets on which the conclusions of the paper rely must be made available" to reviewers during peer review and upon reasonable request after publication.
In practice, researchers seeking access to data can face lengthy application processes, outright refusals, or fees that make independent scrutiny difficult or impossible.
Patient privacy is essential, but it need not preclude independent scrutiny.
Researchers can be given controlled access through secure systems , while independent audits can verify whether research datasets accurately reflect the original records without exposing patients' identities.
At the very least, there should be a clear audit trail showing how the original records were turned into the dataset used in the study.
Medicine's New Black Box The problem exists at both ends.
Before researchers see the data, patient records have already been extracted, enhanced, coded, and transformed. After publication, independent researchers may be unable to obtain the dataset to check the findings for themselves.
Between the two sits an increasingly powerful layer of commercial data companies and research networks controlling how medical information is processed and who gets to see it.
Surgisphere was not simply an isolated pandemic scandal. It exposed a weakness in a research system increasingly dependent on enormous datasets that few people evaluating the resulting science will ever see.
Six years later, the datasets are vastly larger, the software more complex, and their influence over healthcare greater than ever.
The NIH now says research data should have traceable "provenance and lineage." That standard should extend through the entire research chain.
Researchers must be able to examine the underlying data themselves , or there must be an independent way to verify where the data came from and how they were processed.
Otherwise, "accessed and verified" risks becoming little more than a box to tick , while medicine is still being asked to trust the black box.
Tyler Durden
Wed, 11/18/2026 - 19:40
Close
Thu, 19 Nov 2026 00:20:00 +0000 Texas County Kills SpaceX Tax Break As Musk's Lone Star Welcome Wears Thin
Texas County Kills SpaceX Tax Break As Musk's Lone Star Welcome Wears Thin
If you needed a reminder that Texas just turned blue - Cameron County commissioners on Tuesday killed SpaceX's bid for a 10-year, 100% property tax a
Read more.....
Texas County Kills SpaceX Tax Break As Musk's Lone Star Welcome Wears Thin
If you needed a reminder that Texas just turned blue - Cameron County commissioners on Tuesday killed SpaceX's bid for a 10-year, 100% property tax abatement on its planned $24 billion data center and gas-fired power plant near Starbase , voting 3-2 against scheduling the public hearing the deal needed, the Brownsville Herald reported.
County Judge Eddie Treviño Jr. and Precinct 2 Commissioner Joey Lopez voted to move ahead; Commissioners Sofia Benavidez, David Garza and Gus Ruiz voted no. Lopez, who said he wanted the hearing so the court could review the numbers, told KRGV afterward: "as of right now, there won't be a second meeting. So the [request] is dead."
Without the tax abatement, SpaceX said it would "redirect current and/or future investment to other super compute facility sites outside Cameron County," the Herald reported.
SpaceX filed its application on Oct. 15 and revised it on Nov. 9. According to a county presentation reported by the RGV Business Journal , the project carries $24 billion in capital investment, an estimated $13.8 billion in taxable value in its first year and 500 new jobs. The vote followed several hours in executive session, and the hearing commissioners declined to notice would have been held Dec. 29.
SpaceX's Starship vehicle sits fully stacked at the company's Starbase facility in South Texas in April 2023, ahead of a planned orbital test flight attempt. (Image credit: SpaceX via Twitter)
The site is 444 acres that the city of Brownsville de-annexed earlier this year at SpaceX's request, and that Starbase has since annexed . Brownsville itself put a 90-day moratorium on data centers in place on Nov. 4.
"A terrible mistake for Texas, but it's what the people voted for," wrote X user Matthew Cone, sharing that line and wondering "how quickly they pivot to Louisiana or Florida."
The vote lands two weeks after Democrats swept Texas' statewide races. Governor-elect Gina Hinojosa said the day after the election that "we need to stop what we are doing with data centers until we have those protections," as we reported , and she has since asked the state parks department to hold off on a proposed sale of Boca Chica state land to SpaceX until she takes office in January.
Florida, for one, is already making its pitch: Rep. Carlos Gimenez has invited Musk to move Tesla's headquarters to the Sunshine State as Democrats line up probes of his companies.
SpaceX's first county deal, a 10-year abatement signed in 2014 , brought the launch site to Boca Chica; by 2024, the county said, citing figures SpaceX supplied, the company had invested more than $3 billion in Starbase and employed or contracted more than 3,400 people.
Super Heavy's 33 Raptor 3 engines fire at liftoff of Starship Flight 15 from Starbase, Texas, on Nov. 13. Credit: SpaceX
SpaceX's separate request now goes to the City of Starbase, where two of the three commissioners who will rule on it work for SpaceX : Mayor Bobby Peden, the company's vice president of Texas test and launch, and Commissioner Jordan Buss, its senior director of environmental, health and safety, according to Newsweek . The city's public notice sets the hearing on the abatement and a companion economic development agreement for Dec. 9 , without stating the size or length of the break.
Tyler Durden
Wed, 11/18/2026 - 19:20
Close
Thu, 19 Nov 2026 00:00:00 +0000 New York Will Force Unskippable Warnings On Social Media - Unless You Prove Your Age
New York Will Force Unskippable Warnings On Social Media - Unless You Prove Your Age
New York Will Force Unskippable Warnings On Social Media - Unless You Prove Your Age
Authored by Dan Frieth via Reclaim The Net ,
Every day, millions of New Yorkers access social media to read the news, check in on friends, watch a lecture, attend a religious service, debate politics, learn something new, or share a photograph.
Starting January 1, 2027, they will all be interrupted by a message from the state of New York, lasting at least ten seconds , thanks to a law that is now being challenged in court by NetChoice, a trade group.
The law, Senate Bill 4505, amended by Senate Bill 8827 , was signed by Governor Kathy Hochul in December 2025, and the attorney general, Letitia James, is now being sued in a federal court in Manhattan to stop it from taking effect .
The law says that social media companies must show a warning label, written by the state, that users cannot skip. The only way to avoid it is if the platform has "reasonably determined that the user is over seventeen years of age." But the law does not say how this is to be done, and the attorney general is yet to come up with rules on that.
The complaint mentions that the attorney general is authorized to come up with rules and regulations to enforce the law, but notes that the law itself does not provide any guidance on how to implement the age exemption.
This is a crucial point, because the warning is shown to all users by default - and the only way to avoid it is to prove to the platform that you are over 17. But how platforms are to determine this is left unexplained, and the attorney general is yet to come up with rules.
However, it is not hard to figure out what the "guidance" will be, given that the New York government already has a law in place, the SAFE for Kids Act, that is due to come into force on January 25, 2027. And that law defines "age assurance" as "any type of age estimation, age inference, or age verification."
In other words, the warning that the state is about to start forcing social media to show to their users will likely require those users to verify their age if they want to be able to use the platforms without interruptions. And the way to do that will be either to show government-issued ID, or use some other method, such as "zero-knowledge proof" - a cryptographic technique that proves something is true without revealing the information itself.
In July, when the SAFE for Kids rules were announced, the attorney general was asked if they raised privacy concerns, and replied, "not a question of privacy."
The SAFE for Kids Act is not the only one that contains a reference to age verification. S.9051-B , a law that regulates the use of chatbots, and was signed on October 28, says that platforms can offer full features of their chatbots only if they "used methods that are permissible under article forty-five" - that is, the same methods spelled out in the SAFE for Kids Act.
In other words, the chatbot law lets platforms offer full features only to users whose age has been checked.
What the warning label, which will start appearing on New York-based social media users' screens on January 1, says is that "excessive use" of the platforms "may be associated with significant mental health harms."
The first time the message appears each day, it will be shown for at least ten seconds, without the possibility to "bypass or click through the warning," and will cover at least 25% of the screen or window. After three hours of "cumulative active use" and then every hour, the message will appear for at least 30 seconds, covering at least 75% of the screen. These are minimums, and the law does not specify the maximums.
The complaint, which asks for declaratory and injunctive relief, argues that the law is a clear violation of the First and Fourteenth Amendments , as it compels speech, forces users to see the message, and uses vague definitions of who is covered by the law.
The warning is not attributed to the state, and must be presented as if it were the website's own speech. Platforms are not allowed to hide the warning in their terms of service, and are not allowed to use any design that "intentionally serves to inhibit or subvert the purpose of this article." But the law does not define this phrase, and the complaint argues that if it means preventing platforms from responding to the warning, then it is a viewpoint-based restriction that the government is not allowed to impose.
The law also allows the attorney general to impose "civil penalties of up to five thousand dollars per violation" on platforms that do not comply, as well as restitution, disgorgement, and damages.
Furthermore, showing the label does not "waive, release, otherwise limit, or serve as a defense to, any claim, including claims premised on failure to warn."
The complaint lists several platforms that are covered by the law, including Facebook, Instagram, Threads, TikTok, YouTube, Reddit, Pinterest, Tumblr, and X.
The original bill, S.4505, was amended by S.8827, and the changes included limiting the scope of the law from "addictive feed, push notifications, autoplay, infinite scroll, and/or like counts" to "an addictive feed, autoplay, and/or infinite scroll."
The original bill had tasked the commissioner of mental health with writing the label, updating it every year, and deciding on the timing and duration of its appearance on users' screens. The amendment repealed that and instead wrote the text and timing of the warning into the bill.
Another difference between the two versions of the bill is that the original one did not contain the over-17 exemption, while the amendment introduced it.
The complaint argues that the law violates the First Amendment by compelling speech, and quotes the Supreme Court's 1977 ruling in Wooley v. Maynard , which said that free speech "include[s] both the right to speak freely and the right to refrain from speaking at all."
The complaint also argues that the science is not on the side of the New York legislature , as a National Academies review "did not support the conclusion that social media causes changes in adolescent health at the population level," while a 46-study meta-analysis found that "the current pool of research is unable to support claims of harmful effects for social media use on youth internalizing disorders."
The lawsuit also says that the wording of the warning is not supported by the surgeon general's advisory it references, which spoke of "excessive and problematic" use of social media, and that the state's law is using "contested policy and scientific judgments dressed up as factual warnings and forced into the mouths of private speakers."
NetChoice's Paul Taske said, "The First Amendment forbids New York from forcing private speakers to serve as government mouthpieces , and that includes compelled state-scripted warnings on speech" and "New York has every right to share its views on social media, but it has no right to make private websites say it for them."
In January, we wrote about the law, saying that "New York has turned the act of scrolling into a public health intervention."
In July, we reported that Attorney General James was pushing TikTok toward "more age-gating, which means checking everyone's age."
A similar warning label law in Colorado was blocked in November 2025 in the NetChoice v. Weiser case, and is now on appeal before the Tenth Circuit, with no argument date set.
New York's law is what the state itself calls a "warning" - but the state writes the words, hides its own name, blocks the screen, and offers the only exit from this "warning" to people who prove their age.
In reality, the label is the compelled speech, and the age check is the exemption.
Tyler Durden
Wed, 11/18/2026 - 19:00
Close
Wed, 18 Nov 2026 23:40:00 +0000 Stunning Moment "World's Most Endangered Tribe" Makes Rare Contact With Outsiders
Stunning Moment "World's Most Endangered Tribe" Makes Rare Contact With Outsiders
Stunning Moment "World's Most Endangered Tribe" Makes Rare Contact With Outsiders
Members of the Awá tribe, dubbed the "world's most endangered tribe ," have stunned villagers after emerging from the depths of the Brazilian rainforest in a rare encounter with the outside world.
Roughly 20 members of the isolated Indigenous group, including women and children, approached a government outpost in Brazil's northeastern Maranhão state on Monday , marking their first known encounter of this kind in decades, Reuters reports.
VIDEO
The group reportedly asked for yams before disappearing back into the forest with their food, according to Survival International . The Indigenous rights organization warned that illegal loggers, hunters and cattle ranchers have been steadily destroying the tribe's ancestral hunting grounds.
"This is a troubling indication of how the continued invasion of uncontacted peoples' forests puts otherwise self-sufficient Indigenous people in real danger," said the organization's director, Caroline Pearce. "The uncontacted Awá are under extreme pressure as intruders encroach from all sides of their territory , driving them into an ever-smaller island of the Amazon rainforest, surrounded by destruction."
"The Brazilian government must commit the resources necessary to protect Arariboia from the loggers and ranchers who are razing it, in flagrant defiance of the law," Pearce added .
The Awá have survived for generations by hunting, fishing and gathering food while avoiding contact with outsiders. Local Indigenous leaders also expressed alarm over the physical condition of some tribespeople, particularly children and the elderly, who reportedly appeared severely underweight , according to AFP .
VIDEO
Brazilian authorities have activated emergency health precautions, fearing that exposure to common infectious diseases could prove devastating for the isolated community .
Tyler Durden
Wed, 11/18/2026 - 18:40
Close
Wed, 18 Nov 2026 23:20:00 +0000 "Bad Form To Blow Up Repeatedly": Twice-Burned Leopold Aschenbrenner Plots "Situational Awareness 2.0"... This Time With More Leverage
"Bad Form To Blow Up Repeatedly": Twice-Burned Leopold Aschenbrenner Plots "Situational Awareness 2.0"... This Time With More Leverage
Some people learn from blowing up. Others raise more money.
Four months after his AI hedge
Read more.....
"Bad Form To Blow Up Repeatedly": Twice-Burned Leopold Aschenbrenner Plots "Situational Awareness 2.0"... This Time With More Leverage
Some people learn from blowing up. Others raise more money.
Four months after his AI hedge fund went from $20 billion-plus to needing a firesale rescue from Ken Griffin, and two months after he tried to win it all back with out-of-the-money calls (more on those in a second), 25-year-old Leopold Aschenbrenner is plotting a comeback. According to the FT , he has spent recent weeks discussing a new iteration of Situational Awareness, which would include a return to leveraged trading and fresh outside capital , an effort that has been dubbed, and we are not making this up, "Situational Awareness 2.0" (technically it's 3.0 - see below - but he probably thinks his investors are so dumb they can't count that high) in conversations with prime brokers and investors.
One of those investors put it best: "It's bad form to blow up repeatedly."
It certainly is. Which is why we have spent so much time over the past five months making fun of the "hilariously misnamed hedge fund" and its founder: because for all the brilliance of the essay, the trading record looks a lot less like a "Nostradamus of AI" and a lot more like a Robinhood account with a Goldman prime brokerage agreement.
Blow-Up #1: The Swaps Long-time readers will recall that we were sniffing around for the AI version of Archegos well before anyone knew his name. Back in mid-June, as total return swap funding costs went vertical, we asked the obvious question:
...and three days later we wrote that futures funding rates were exploding amid soaring TRS demand to chase the market higher (Jun 15). We just didn't know who it was. By late July we did: Situational Awareness blew up , its assets reportedly collapsed from $45 billion to $10 billion in less than a month , and most of the public book was dumped on Citadel at a discount, with the proceeds used to pay off prime lenders including Goldman and JPMorgan. In hindsight (as we had warned) the entire chip/memory melt-up was little more than leverage dressed up as narrative, and the trade peaked on the very day TRS funding costs hit a record:
Goldman's Prime Services desk, which had a front-row seat (and, as the FT reported in September, reaped more than $200 million in fees from the fund along the way), later showed just how far the "AI enablers vs. disrupted" trade (aka the Leopold trade) had gone: semis as a share of total prime book net exposure went parabolic into the summer while software collapsed to near zero, before "the July deleveraging" broke the fever:
And who made out like a bandit? The guy on the other side. Citadel's flagship jumped 6% in July thanks to the Leopold swoop, and within weeks Griffin had flipped almost all of the stocks he scooped up. Billions in profit, virtually no risk. Meanwhile, the Dario curse struck again:
Blow-Up #2: The Revenge Trade Now, any retail trader who has ever been margin called knows exactly what comes next: the revenge trade. Bigger size, shorter dated, further out of the money, because you need to make it all back fast .
Leopold did precisely that. In early September, Nomura's Charlie McElligott flagged a "mystery buyer " spending roughly $315 million in premium on deep out-of-the-money January flex calls in the exact same names that had blown up in July: AMD, Bloom Energy, CoreWeave, the DRAM memory ETF, Intel, SK Hynix and Sandisk. Our first reaction, as we wrote at the time, was that nobody could possibly be dumb enough to rerun the identical trade with a giant bullseye on his back. Two days later the FT confirmed that Situational Awareness was placing large new flex-option bets and rebuilding positions in... AMD, Intel, SK Hynix, Sandisk and CoreWeave. Hence "Leopold Is Back: Situational Awareness Rerunning Exact Same Trades Which Blew It Up A Month Ago " (Sep 11), and the same evening the FT reported that JPMorgan had cut off lending to the fund .
A week later, "somebody" went full WallStreetBets, dropping some $100 million in premium on calls that expired in just two weeks:
And here, in fairness (we are nothing if not fair), a confession: those particular lottery tickets actually hit. On the Oct 2 expiration Micron closed at $1,074.89, Sandisk at $1,719.99, Marvell at $272.29 and Intel at $119.33, all above their strikes. Held to expiry, the $96 million of premium would have been worth roughly $142 million at intrinsic value, a ~47% gain in two weeks (assuming whoever "somebody" was didn't sell early). Even a broken clock...
The problem, as every retail trader also knows, is what happens after the lottery ticket pays: you buy more. The quarter-end 13F, which we broke down in detail on Monday , shows that after the July liquidation the public book shrank from $20.24 billion to $1.58 billion , with 21 of 26 lines closed, and that of what was left, 66% was call options : Bloom Energy calls (raised tenfold to $389 million notional), plus new calls on Nebius ($333 million), Sandisk ($183 million) and a memory ETF ($140 million), alongside a $441 million slug of SharonAI stock.
And then came October and November. The AI trade cracked, hedge funds dumped AI exposure for days on end, and, per Goldman's Prime Services data , the entire cumulative net buying of AI stocks by hedge funds since the start of 2025 was wiped out...
... with net allocation to global AI stocks falling from 31.7% at the June peak to 26.1% by mid-October (as we noted in "Leopold Lows 2.0? " on Oct 15, where a CoreWeave November call that traded at $18 in early September was quoted at $1). UBS's Torsten Sippel went further, writing that the October action looked very similar to the Situational Awareness unwind , and on Nov 5, when the Nasdaq had its worst day since Covid, Vanda found that the names Leopold held in June were among the heaviest retail sales . Leopold's ghost portfolio, as it were.
Here is what happened to the post-blowup book since Sept. 30: every underlying is down between 36% and 58%.
For the calls, we don't know the strikes or expiries (a 13F doesn't say), but with the underlyings cut roughly in half, a book that was two-thirds upside calls has probably been crushed. As for the January flex calls from early September, here is how far each stock would have to rally from today's price just to get back to the strike , never mind pay back the premium:
Translation: with the exception of AMD, Sandisk needs to nearly triple, CoreWeave and Intel need to more than double, and the rest need 50-80% rallies in two months. We'd call that a long shot, but that would be unfair to long shots.
Which brings us to Monday night's tweet, which summed up the whole saga in one line:
Situational Awareness 2.0, Now With Leverage So what does any self-respecting blown-up retail trader do next? Well, he reopens the margin account (assuming someone is dumb enough to let him) . Let's run through the checklist, courtesy of the FT:
The pledge: in July, Aschenbrenner sent investors a mea culpa promising he would no longer borrow from banks to amplify his bets. Four months later he is discussing a return to leveraged trading .Broker-hopping: JPMorgan cut him off after the July debacle. Jefferies turned him away earlier this year because it felt the fund wasn't appropriately hedged, and he has since been back in talks with Jefferies about a prime brokerage account, while also working with specialist broker Clear Street (which, as we pointed out in September , happens to be the biggest provider of swaps to levered ETFs).Fresh capital: he has also discussed raising more money from outside investors in the new year.The lesson learned: a second investor who recently spoke to management summed up what the firm has taken away from losing tens of billions:“all they’ve learnt is [that their] risk management needs a little more fine tuning”
A little fine tuning. For what the FT has called the largest loss in the history of the hedge fund industry.
Whether Jefferies, a bank that recently had the pleasure of counting First Brands and Radiant among its clients, says yes this time around is another matter:
To be fair to the fund, there are some signs of adult supervision: headcount has grown to about 30 from just eight in a June filing, and it is now looking for a chief risk officer , which, for a fund that ran $20 billion-plus of levered memory-chip exposure with no CRO, is maybe the most damning detail in the whole story. The FT also notes that Goldman and JPMorgan had extended financing to Aschenbrenner despite his limited trading experience, which tells you everything about how the banks chased the fees (all $200 million+ of them, in Goldman's case) on the way up.
Great Essay, Terrible Trader None of this means the original thesis was wrong. The 2024 "Situational Awareness" essay called the trillion-dollar compute race, the power bottleneck and the capex boom earlier and more clearly than almost anyone on Wall Street. The idea was right. The positioning, the leverage and the capital allocation were a catastrophe : concentrated, swap-levered longs in the highest-beta names into a funding-cost spike; a forced sale to Citadel at the bottom; a pivot to deep out-of-the-money calls in the exact same names; and a 13F book that went from $20 billion to $1.58 billion in a quarter. Having the right macro call and still losing tens of billions is, if anything, the most retail thing of all.
The irony is that his best trade was the one he couldn't trade. Situational Awareness still manages more than $10 billion, mostly in private investments, including an approximately $5 billion stake in Anthropic , where Aschenbrenner's wife is chief of staff to Dario Amodei, and which is expected to be worth significantly more after the IPO that prices tonight, targeting a valuation of around $1.4 trillion, with trading set to start tomorrow. In other words, the illiquid position nobody could margin call is the one that made money , which is exactly why it's the one that should give investors pause about handing him a liquid, levered book again. (Sam Bankman-Fried, another early Anthropic backer, would have made nearly $40 billion on the IPO, per the FT ; Dario curse, part two.)
Will he get the money? Probably. This is Wall Street, where a $5 billion Anthropic mark and a viral essay buy a lot of forgiveness, and the FT's last word goes to one of his investors:
“Everyone who was a believer before is probably still a believer.”
We don't doubt it. Then again, Archegos also had believers, right up until the morning the prime brokers stopped answering the phone. When Situational Awareness 2.0 shows up at a dealer near you, we suggest keeping an eye on TRS funding rates; last time, they told us everything a month before the FT did.
Much more in the full Nomura McElligott note and Goldman's Prime Services AI positioning note, both available to pro subs .
Tyler Durden
Wed, 11/18/2026 - 18:20
Close